Area of research
Molecular Biology · Orthopedics and Sports Medicine
Research interest
Research interests include Bone Metabolism and Diseases, Bone health and osteoporosis research, Bone health and treatments, and Metabolism, Diabetes, and Cancer.
Associations of circulating omentin-1 levels and long noncoding RNA MALAT1 expression with coronary heart disease in type 2 diabetes mellitus
Associations of circulating omentin-1 levels and long noncoding RNA MALAT1 expression with coronary heart disease in patients with type 2 diabetes mellitus
Denosumab improves glycaemic parameters in postmenopausal osteoporosis patients with combined Type 2 diabetes mellitus
Cadherin‑16 inhibits thyroid carcinoma cell proliferation and invasion
Exosomes Derived From M2 Macrophages Facilitate Osteogenesis and Reduce Adipogenesis of BMSCs
BMSC-Derived Exosomes Inhibit Dexamethasone-Induced Muscle Atrophy via the miR-486-5p/FoxO1 Axis
Curculigoside Ameliorates Bone Loss by Influencing Mesenchymal Stem Cell Fate in Aging Mice
Effects of different doses of metformin on bone mineral density and bone metabolism in elderly male patients with type 2 diabetes mellitus
Bioinformatics Analysis Reveals the Altered Gene Expression of Patients with Postmenopausal Osteoporosis Using Liuweidihuang Pills Treatment
RETRACTED ARTICLE: Association of the polymorphisms in <i>FOXO1</i> gene and diabetic nephropathy risk
Corrigendum to “Bioinformatics Analysis Reveals the Altered Gene Expression of Patients with Postmenopausal Osteoporosis Using Liuweidihuang Pills Treatment”
Liraglutide Promotes the Osteogenic Differentiation in MC3T3-E1 Cells via Regulating the Expression of Smad2/3 Through PI3K/Akt and Wnt/β-Catenin Pathways
Exendin-4 promotes the osteogenic differentiation of osteoblasts via the Hedgehog/Gli1 signaling pathway.
PubMed 2018cited by 10position: last
Prediction of fracture risk in postmenopausal type 2 diabetes mellitus with osteopenia by serum OPG, TGF-β and IL-6 levels
Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin
IGF1 promotes osteogenic differentiation of mesenchymal stem cells derived from rat bone marrow by increasing TAZ expression
Impaired PI3 K Akt expression in liver and skeletal muscle of ovariectomized rats
Bone morphogenetic protein and bone metabolism
Chinese Journal of Osteoporosis and Bone Mineral Research 2013cited by 0position: first